Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

Eitemau Tebyg

• Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
  gan: Xuan Zhang, et al.
  Cyhoeddwyd: (2022-03-01)
• Impact of body composition on pathological response to neoadjuvant immunotherapy in dMMR/MSI-H colorectal cancer
  gan: Ziyang Zeng, et al.
  Cyhoeddwyd: (2025-05-01)
• Immune checkpoint inhibitors in dMMR-MSI-H colorectal cancer: rationale, progress and prospects
  gan: Guangre Xu, et al.
  Cyhoeddwyd: (2026-07-01)
• Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
  gan: Zhu Xi, et al.
  Cyhoeddwyd: (2024-02-01)
• Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer
  gan: Koji Inamori, et al.
  Cyhoeddwyd: (2021-05-01)